P
Patompong Ungprasert
Researcher at Cleveland Clinic
Publications - 311
Citations - 5893
Patompong Ungprasert is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Meta-analysis & Odds ratio. The author has an hindex of 31, co-authored 295 publications receiving 4041 citations. Previous affiliations of Patompong Ungprasert include Mayo Clinic & Siriraj Hospital.
Papers
More filters
Journal ArticleDOI
Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis
TL;DR: The focus of this review is current knowledge about the epidemiology, clinical manifestations, diagnosis, and treatment of both pulmonary sarcoidosis and extrapulmonary sarCOidosis, with a focus on glucocorticoids.
Journal ArticleDOI
Sodium‐glucose cotransporter 2 (SGLT2) inhibitors and fracture risk in patients with type 2 diabetes mellitus: A meta‐analysis
TL;DR: Sodium‐glucose cotransporter 2 (SGLT2) inhibitors could potentially alter calcium and phosphate homeostasis and may increase the risk of bone fracture.
Journal ArticleDOI
A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
Tarinee Rungjirajittranon,Weerapat Owattanapanich,Patompong Ungprasert,Noppadol Siritanaratkul,Theera Ruchutrakool +4 more
TL;DR: Thrombosis and bleeding are common initial manifestations of Philadelphia (Ph) chromosome-negative myeloproliferative neoplasms and Investigations for MPN should be considered for patients who present with unexplained thrombotic events or abnormal bleeding.
Journal ArticleDOI
Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
TL;DR: It is found that the definition of regular coffee consumption varied between studies, which is the main limitation of this meta-analysis, and whether consumption of coffee could be considered a preventative measure against NAFLD needs further investigations.
Journal ArticleDOI
Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis.
TL;DR: High-intensity statins were found to improve a decline in eGFR in population with CKD not requiring dialysis compared with control, but moderate- and low- intensity statin therapy were not.